Istodax approved in U.S. as therapy for previously treated patients with peripheral T-cell lymphoma June 17, 2011
Pilot study supports tolerability of AC-480 in patients with recurrent malignant glioma June 17, 2011
Phase II ARQ-197 trial assesses safety and efficacy in relapsed/refractory non-CNS germ cell tumors June 17, 2011
Sprycel indication expanded in Japan to include first-line treatment of chronic myeloid leukemia June 16, 2011
RSS